|
| 产地 | 中国 |
| 品牌 | Chemstan |
| 货号 | CSD00268 |
| 保存条件 | store at -80℃ |
| 用途 | 仅用于科研用途 |
| 应用范围 | |
| 抗原来源 | CHO cells |
| CAS编号 | 1238217-55-4 |
| 保质期 | 一年 |
| 抗体名 | Vatelizumab ( 伐利组单抗 ) |
| 是否单克隆 | |
| 克隆性 | |
| 靶点 | ITGA2[Homo sapiens] |
| 适应物种 | |
| 形态 | |
| 宿主 | |
| 标记物 | |
| 包装规格 | 100μg |
| 纯度 | % |
| 亚型 | |
| 标识物 | |
| 浓度 | 95% |
| 免疫原 | |
| 是否进口 | 否 |
Vatelizumab has been used in trials studying the treatment of Ulcerative Colitis.
货号（Catalog No.）
CSD00268
通用名INN
Vatelizumab
纯度(Purity)
>95%
浓度( Concentration)
1mg/ml
Formulation
PBS buffer pH7.5
Source
CHO cells
内毒素(Endotoxin level)
Please contact with the lab for this information.
生物活性
产品描述(Description)
Vatelizumab has been used in trials studying the treatment of Ulcerative Colitis.
别名(Alternative names)
GBR500
靶点;物种(Specificity target name;species)
ITGA2[Homo sapiens]
种类(Species)
Humanized
受体鉴定(Receptor identification)
IgG4-kappa
化学信息
CAS
1238217-55-4
存储条件(Storage)
store at -80°C
